Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001886269 | SCV002150406 | uncertain significance | Biotin-responsive basal ganglia disease | 2022-11-29 | criteria provided, single submitter | clinical testing | Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available"). ClinVar contains an entry for this variant (Variation ID: 1380241). This variant has not been reported in the literature in individuals affected with SLC19A3-related conditions. This sequence change replaces valine with alanine at codon 350 of the SLC19A3 protein (p.Val350Ala). The valine residue is weakly conserved and there is a small physicochemical difference between valine and alanine. |